Edge Therapeutics Inc. (EDGE) Securities Investigation

Investigating potential claims –Edge Therapeutics, Inc.

According to reports on Monday, shares of Edge Therapeutics lost almost 92% after the company announced disappointing results from a phase III study, NEWTON 2 on lead pipeline candidate, EG-1962.

The company’s stock has lost 86.7% in the last three months compared with the industry ‘s decline of 4.2%. The loss of 92% in a single day due to failure of the study has reportedly resulted in the stock’s under performance.

Edge Therapeutics, Inc. (Nasdaq:EDGE) is a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions.

The company reportedly will reduce the size of its workforce, in order to preserve cash resources, which were $88.1 million as of Dec 31, 2017 due to the failure of the late-stage study.

Recovery of Investment Losses

The White Law Group is investigating the liability that brokerage firms may have for improperly selling high risk investments like Edge Therapeutics to investors.

Broker dealers are required to perform adequate due diligence on all investment recommendations. They must ensure that each investment recommendation that is made is suitable for the investor in light of the investor’s age, risk tolerance, net worth, financial needs, and investment experience.

Fortunately, FINRA does provide for an arbitration forum for investors to resolve such disputes. If a broker or brokerage firm makes an unsuitable investment recommendation or fails to adequately disclose the risks associated with an investment they may be found liable for investment losses in a FINRA arbitration claim.

To determine whether you may be able to recover investment losses incurred as a result of your purchase of Edge Therapeutics  investment, please contact The White Law Group at 1-888-637-5510 for a free consultation.

The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee. The firm represents investors throughout the country in claims against their brokerage firm.

For more information on the firm and its representation of investors, visit whitesecuritieslaw.com.